SEC Form 4Coverage since May 26, 2026
$KYMR insider trading
Over the last 12 months, Kymera Therapeutics insiders reported no purchases and 16 sales totaling $386.5M across SEC Form 4 filings. 88% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $386.5M 16 events
- Events · 12m
- 16 Form 4 filings, grouped
- Insiders · 12m
- 6 distinct reporters
- 10b5-1 share
- 88% pre-arranged plans
Side
Price · $KYMR · 12Mvia TradingView
Top insiders · 12m
Booth Bruce—7× · $187.3M
Goodman NoahChief Business Officer3× · $1.2M
Mainolfi NelloChief Executive Officer2× · $15.2M
BVF PARTNERS L P/IL—2× · $173.7M
Chadwick Jeremy GChief Operating Officer1× · $292K
All insider trades
16 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Mainolfi NelloChief Executive Officer · O·D | ▼ Sale | 50,000 | $119 | $6.0M | -7% | plan |
| Jul 1, 2026 | Goodman NoahChief Business Officer · O | ▼ Sale | 3,389 | $114.29 | $387K | -6.7% | plan |
| Jul 1, 2026 | Mainolfi NelloChief Executive Officer · O·D | ▼ Sale | 80,000 | $115.29 | $9.2M | -10.7% | plan · 5 tranches |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer · O | ▼ Sale | 77,109 | $114.96 | $8.9M | -23.9% | plan · 8 tranches |
| Jun 29, 2026 | Booth BruceD | ▼ Sale | 31,283 | $109.48 | $3.4M | -6.3% | plan · 8 tranches · indirect |
| Jun 29, 2026 | Booth BruceD | ▼ Sale | 513,245 | $110.01 | $56.5M | -52.4% | plan · 30 tranches · indirect |
| Jun 26, 2026 | BVF PARTNERS L P/ILD | ▼ Sale | 51,858 | $106.5 | $5.5M | -39.7% | indirect |
| Jun 26, 2026 | BVF PARTNERS L P/ILD | ▼ Sale | 1,578,800 | $106.5 | $168.1M | -86.8% | 3 tranches |
| Jun 25, 2026 | Booth BruceD | ▼ Sale | 285,684 | $121.86 | $34.8M | -35% | plan · 22 tranches · indirect |
| Jun 25, 2026 | Booth BruceD | ▼ Sale | 398,765 | $110.31 | $44.0M | -41.4% | plan · 30 tranches · indirect |
| Jun 25, 2026 | Goodman NoahChief Business Officer · O | ▼ Sale | 5,000 | $114 | $570K | -9.1% | plan · 2 tranches |
| Jun 22, 2026 | Booth BruceD | ▼ Sale | 31,798 | $103.75 | $3.3M | -4.9% | plan · 4 tranches · indirect |
| Jun 22, 2026 | Booth BruceD | ▼ Sale | 466,457 | $94.84 | $44.2M | -43% | plan · 28 tranches · indirect |
| Jun 22, 2026 | Goodman NoahChief Business Officer · O | ▼ Sale | 2,500 | $99 | $248K | -4.7% | plan |
| Jun 17, 2026 | Booth BruceD | ▼ Sale | 11,741 | $89.98 | $1.1M | -100% | plan |
| May 26, 2026 | Chadwick Jeremy GChief Operating Officer · O | ▼ Sale | 3,730 | $78.36 | $292K | -6.1% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $KYMR feed.